Background and Objective: The global population is struggling with significant health challenges, among which overweight and obesity stand out. Currently, 61% of adults and 7.5% of children and adolescents are affected, underscoring the urgent need for effective solutions. This study evaluated appetite-reducing prototypes related with food products, focusing on their ability to influence appetite through the sense of smell. The objective was to determine the effectiveness of these prototypes and identify the most promising candidates for further research. Methods: A questionnaire-based consumer survey was performed for six appetite-reducing agents. Forty-five participants with elevated body mass index values (BMI ≥ 25) were asked to verify the samples in terms of aroma intensity, pleasure, and potential for appetite reduction. Also, qualitative parameters such as the identification of the samples’ food associations was performed within the questionnaire. The questionnaire results were further compared with headspace solid-phase microextraction (HS-SPME Arrow) analysis results to identify volatile organic compounds associated with appetite-reducing properties. Results: The proof-of-concept study revealed that prototypes with unpleasant and irritating aromas demonstrated the highest appetite-reducing potential, scoring approximately 24 out of 35 points. Conversely, prototypes with pleasant, dessert-like aromas showed lower effectiveness, scoring between 14 and 18 points. Conclusions: By linking consumer perceptions to chemical analyses, we identified effective prototypes for further investigation, including studies measuring actual food intake. These findings contribute to developing innovative, non-invasive strategies to address overweight and obesity, offering a new dimension to appetite control through sensory modulation.

This study investigates the production of volatile organic compounds (VOCs) in RK-13 cells infected with three equine viruses representing different families: equine arteritis virus (EAV) (Arteriviridae), equine herpesvirus 1 (EHV-1) (Herpesviridae), and equine rhinitis B virus (ERBV) (Picornaviridae). VOCs, which are byproducts of cellular metabolism and potential non-invasive diagnostic markers, were analyzed using headspace solid-phase microextraction (HS-SPME) and gas chromatography–mass spectrometry (GC-MS). Since viruses do not possess intrinsic metabolic activity, the observed changes in the VOC profiles were attributed to host responses, such as metabolic reprogramming, oxidative stress, and apoptosis. We hypothesized that each viral infection induces distinct metabolic changes, resulting in characteristic VOC signatures that mirror the virus type, replication kinetics, and cytopathic effects. Notably, viruses with rapid cytopathic effects (e.g., EHV-1) were anticipated to trigger more pronounced VOC alterations. In our experimental design, RK-13 cells were infected at a multiplicity of infection of 1 and incubated for 24 h, 48 h, or 72 h. Distinct VOC profiles emerged, with significant elevations in compounds like 2-ethyl-1-hexanol, particularly in EHV-1 infections, and selective increases in acetophenone and benzaldehyde. Principal component analysis (PCA) of the VOC concentration data showed the clear separation of data from viruses from different families. These findings support the potential of VOC profiling as a rapid diagnostic tool for viral infections.